Table of Contents

Washington University Experience | NEOPLASMS (HEMATOLYMPHOID) | Lymphoma, immune-compromised | 6C1 Lymphoma (Case 6) CD20 2

6C1,2 Immunohistochemical studies show tumor cells to be positive for B-cell markers LCA and CD20.

---